| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271164 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders |
| 09/18/2007 | US7271163 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 09/18/2007 | US7271162 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 09/18/2007 | US7271153 Treating diseases associated with hyperglycemia such as diabetes; SGLT2 (sodium/glucose cotransporter 2) inhibitor; 3-(4-Ethylbenzyl)-2-(beta-D-glucopyranosyloxy)-4,6-dimethyl-pyridine for example |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271149 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/18/2007 | CA2184733C Spin encapsulation apparatus and method of use |
| 09/13/2007 | WO2007104053A2 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 09/13/2007 | WO2007104034A2 Glucokinase activators |
| 09/13/2007 | WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102467A1 Aqueous solution of conophylline and/or conophyllidine |
| 09/13/2007 | WO2007102440A1 Agent for improvement in adipocytokine production |
| 09/13/2007 | WO2007102439A1 Fractionation product of aqueous extract of eucommia ulmoides oliver leaf, and composition for oral ingestion comprising the fractionation product |
| 09/13/2007 | WO2007102438A1 Fractionation product of aqueous extract of eucommia ulmoides oliver leaf, and anti-obesity agent comprising the fractionation product |
| 09/13/2007 | WO2007101935A2 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/13/2007 | WO2007101531A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases |
| 09/13/2007 | WO2007101349A1 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 09/13/2007 | WO2007082808A3 Thiazoles as 11 beta-hsd1 inhibitors |
| 09/13/2007 | WO2007071766A3 Phenoxy acetic acids as ppar delta activators |
| 09/13/2007 | WO2007030559A3 1, 3-disubstituted indole derivatives for use as ppar modulators |
| 09/13/2007 | WO2007002972A3 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 09/13/2007 | WO2006079107A3 Transplantation compositions and methods for treating diabetes |
| 09/13/2007 | WO2006024627A3 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/13/2007 | US20070213408 Use of Acetyl L-Carnitine for the Preparation of a Medicine for the Treatment of Neuropathic Pain in Diabetic Patients |
| 09/13/2007 | US20070213400 Alcohol-metabolism enhancing composition and ingesta containing the same |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213364 Alkoxyphenylpropanoic Acid Derivatives |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070213280 Steroidal Saponins Compound, the Process for Producing the Same and the Use Thereof |
| 09/13/2007 | US20070212769 Transfection, culturing; electrophoresis |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | DE60124710T2 Analoge des glucagon ähnlichen peptid-1 Analogs of glucagon-like peptide-1 |
| 09/13/2007 | DE102004028241B4 Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and Manufacturing of these products |
| 09/13/2007 | CA2646429A1 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 09/13/2007 | CA2645719A1 Compounds that modulate ppar activity, their preparation and use |
| 09/13/2007 | CA2644996A1 A2a adenosine receptor antagonists |
| 09/13/2007 | CA2644166A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases |
| 09/13/2007 | CA2643694A1 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/13/2007 | CA2643385A1 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832584A1 Pyrimidinylisoxazol derivative |
| 09/12/2007 | EP1832576A1 4-Biarylyl-1-phenolyzetidin-2-ones |
| 09/12/2007 | EP1832291A2 use of pyridoxal phosphate for the treatment of diabetes and related complications |
| 09/12/2007 | EP1832284A1 Adiponectin inducer or secretagogue |
| 09/12/2007 | EP1832181A2 Microbial oil mixtures and uses thereof |
| 09/12/2007 | EP1832179A1 Carbohydrate fraction composition and flat glucose response |
| 09/12/2007 | EP1831683A1 Methods of modulating the activities of alpha7 nicotinic acetylcholine receptor |
| 09/12/2007 | EP1831371A2 Muteins of fibroblast growth factor 21 |
| 09/12/2007 | EP1831252A1 Glp-1 analog fusion protein formulations |
| 09/12/2007 | EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 09/12/2007 | EP1831188A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 09/12/2007 | EP1831151A1 Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2s) -2-ethoxy-3- (4-{2- [hexyl (2- phenylethyl) amino]- 2 -oxoethoxy} phenyl) propanoic acid |
| 09/12/2007 | EP1830841A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1830840A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/12/2007 | EP1830837A2 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| 09/12/2007 | EP1830832A1 Zinc-containing treatments for hyperphosphatemia |
| 09/12/2007 | EP1830830A2 Omega-3 fatty acids and dyslipidemic agent for lipid therapy |
| 09/12/2007 | EP1682528B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES |
| 09/12/2007 | EP1654263B1 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 09/12/2007 | EP1613304B1 Dpp-iv inhibitors |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 09/12/2007 | EP1519925B1 Oxazole derivatives and their use as insulin sensitizers |
| 09/12/2007 | EP1465641B1 Pharmaceutical products comprising deuterium for the treatment of diabetes |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1354945B1 Method of identifying within a rodent a dna encoding physiologically active polypeptide |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP1268305B1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/12/2007 | EP1133312B1 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes |
| 09/12/2007 | CN101035767A Substituted phenylacetamides and their use as glucokinase activators |
| 09/12/2007 | CN101035762A Alkil-pyridines as 11-beta inhibitors for diabetes |
| 09/12/2007 | CN101035557A A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| 09/12/2007 | CN101035548A Steroidal saponin pharmaceutical composition, the preparation method and use thereof |
| 09/12/2007 | CN101035522A Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin |
| 09/12/2007 | CN101032609A Healthy product having function of losing weight |
| 09/12/2007 | CN101032599A Healthy solution for conditioning skin and losing weight |
| 09/12/2007 | CN101032595A Energy source capsule and the preparing method |
| 09/12/2007 | CN101032592A Novel formula of pure Chinese traditional medicine agent and the preparing method |
| 09/12/2007 | CN101032591A Novel formula of pure Chinese traditional medicine agent |
| 09/12/2007 | CN101032567A Healthy product for losing weight |
| 09/12/2007 | CN101032564A Health preserving wine for conditioning blood-fat and the preparing method |
| 09/12/2007 | CN101032562A Health care product having functions of conditioning blood pressure and protecting haemal system of heart and brain |